Skip to main content

Use of drugs in the ICU and its iatrogenic potential


Developed and administered for the purpose of benefit, pharmaceutical agents can cause harmful effects to the patient. We analyzed their use in a population of patients admitted to the ICU, trying to detect their potential exposure to drug-drug interactions.


Prospective study of patients hospitalized for more than 48 hours, during the period from May to July 2012, with tracking of drug interactions according to Micromedex (Version 2.0).


We analyzed 50 patients with a mean age 45.4 ± 18.7 years, the majority were female (54%) and from the emergency unit (74%). The mean APACHE II score was 17.6 ± 7.3 points, the mean SOFA score (day 1) 7.3 ± 4.2 points, and the median length of stay 21 (IQR: 12.5 to 31.5) days. One hundred and three drugs were prescribed, predominantly antimicrobials (100% of patients) and analgesics (98% of patients). The average/day/patient of prescription drugs was 10 ± 2.6, and the average/day/patient drug interactions 2.7 ± 2.8. On exposure to drug interactions important and moderate risk occurred, respectively, in 78% and 86%, identifying the association contraindicated in 34% of patients of a positive correlation between length of stay in the ICU and exposure to important risk interactions (r = 0.53, P = 0.00006) and moderate risk interactions (r = 0.34, P = 0.013). Patients exposed to important risk interactions had greater severity at ICU admission for the APACHE II (18.5 ± 7.1 vs. 14.3 ± 6.9 points, P = 0.045) and SOFA (day 1) (7.8 ± 4 vs. 4.2 ± 3.9 points, P = 0.017).


The high numbers of drug interactions with important risk incidents, especially in the sick population, alert us to the necessity of knowledge by the intensivist for the use of drugs, due to the iatrogenic potential exacerbating the severity already underway.


  1. Hammes JA, et al.: Prevalence of potential drug-drug interactions in intensive care units. Brazilian J Intensive Care 2008, 20: 349-354.

    Google Scholar 

  2. Rossignoli PdS, Guarido CF, Cestari IM: Occurrence of drug interactions in the intensive care unit: evaluation of medical prescriptions. Brazilian J Pharmacol 2006, 87: 104-107.

    Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

de Castro Vieira, É., Vidal, N., Fideles, G. et al. Use of drugs in the ICU and its iatrogenic potential. Crit Care 17 (Suppl 3), P16 (2013).

Download citation

  • Published:

  • DOI:


  • Public Health
  • Drug Interaction
  • Emergency Medicine
  • Harmful Effect
  • Prescription Drug